Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
flutiform versus fluticasone and beclometasone lower-leg growth safety study in children with mild persistent asthma
2013-004719-32Phase 2Completed
- Sponsor
- Mundipharma
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of fluticasone propionate + formoterol, fluticasone propionate and beclomethasone dipropionate in asthma (3 arms), sponsored by Mundipharma. Primary endpoint: Mean lower leg growth rate during each period. Started Jan 2014; status: completed.
02
Drugs
fluticasone propionate + formoterolfluticasone propionatebeclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2013-004719-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004719-32.